Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

142
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
142
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

149
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
149
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

279
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
279
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

193
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
193
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

451
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
451
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

403
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
403

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esophageal motility disorders after COVID-19 infection.

Scientific reports·2025
Same author

Serum proteins and faecal microbiota as potential biomarkers in newly diagnosed, treatment-naïve inflammatory bowel disease and irritable bowel syndrome patients.

Journal of molecular medicine (Berlin, Germany)·2025
Same author

Incidence, Risk Factors and Mortality Associated with Major Bleeding Events in Hospitalized COVID-19 Patients.

Life (Basel, Switzerland)·2023
Same author

Correlation of ex vivo cytokine secretion profiles with scoring indices in ulcerative colitis.

European journal of clinical investigation·2023
Same author

Short-term outcomes of patients with chronic liver disease hospitalised with COVID-19.

Internal medicine journal·2022
Same author

OPPORTUNISTIC SCREENING FOR COLORECTAL CANCER IN HIGH-RISK PATIENTS IN FAMILY MEDICINE PRACTICES IN THE REPUBLIC OF CROATIA.

Acta clinica Croatica·2022

Related Experiment Video

Updated: Sep 7, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.7K

MODERN APPROACH TO DYSPEPSIA.

Barbara Medić1, Žarko Babić1, Marko Banić1

  • 11Zagreb Health Center-Center, Zagreb, Croatia; 2Department of Gastroenterology, Hepatology and Clinical Nutrition, Dubrava University Hospital, Zagreb, Croatia; 3School of Medicine, University of Zagreb, Zagreb, Croatia; 4Division of Interventional Gastroenterology, Dubrava University Hospital, Zagreb, Croatia; 5School of Medicine, University of Rijeka, Rijeka, Croatia; 6Division of Inflammatory Bowel Disease and Clinical Nutrition, Dubrava University Hospital, Zagreb, Croatia.

Acta Clinica Croatica
|June 23, 2022
PubMed
Summary
This summary is machine-generated.

Functional dyspepsia (FD) involves upper abdominal pain related to digestion, without an identifiable organic cause. Research aims to understand its complex mechanisms for better treatment of this growing condition.

Keywords:
DyspepsiaHelicobacter pyloriHypersensitivityMicrobiotaVisceral pain

More Related Videos

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
06:46

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

2.9K
Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

618

Related Experiment Videos

Last Updated: Sep 7, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.7K
Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
06:46

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

2.9K
Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

618

Area of Science:

  • Gastroenterology
  • Internal Medicine

Background:

  • Functional dyspepsia (FD) is a common gastrointestinal disorder characterized by epigastric symptoms linked to digestion.
  • Unlike organic dyspepsia, FD lacks an identifiable underlying organic pathology.
  • Increasing prevalence makes FD a significant gastroenterological diagnosis.

Purpose of the Study:

  • To elucidate the complex mechanisms underlying functional dyspepsia.
  • To identify potential therapeutic targets for improved patient outcomes.
  • To reduce the diagnostic and treatment costs associated with FD.

Main Methods:

  • Diagnosis relies on patient history, clinical presentation, and exclusion of organic diseases.
  • Current therapies include *Helicobacter pylori* eradication, proton pump inhibitors, prokinetics, neuromodulators, and herbal treatments.
  • The study emphasizes the need for further research into FD pathophysiology.

Main Results:

  • Despite available treatments, some patients experience limited or no symptom improvement.
  • Multiple factors are implicated in FD onset, including immune and mucosal changes, gastric dysmotility, altered gut microbiota, and central nervous system processing.
  • The effectiveness of current therapies varies among individuals.

Conclusions:

  • Further elucidation of FD mechanisms is crucial for developing effective and personalized therapies.
  • Addressing the underlying causes of FD is essential for improving patient management and reducing healthcare burden.
  • Targeted therapeutic strategies are needed for different patient subgroups experiencing refractory symptoms.